NCT05264077View on ClinicalTrials.gov

Efficacy of Dexmedetomidine vs Midazolam for Early Extubation in Critically Ill Agitated Patients Undergoing Weaning

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

July 31, 2025

Conditions

Agitation, Emergence

Interventions

DRUG

Dexmedetomidine Hydrochloride

Inj dexmedetomidine and inj midazolam given to two groups of participants and effects of both drugs will be observed for 24 hrs

All Listed Sponsors

lead

Sheikh Zayed Medical College

OTHER_GOV

NCT05264077 - Efficacy of Dexmedetomidine vs Midazolam for Early Extubation in Critically Ill Agitated Patients Undergoing Weaning | Biotech Hunter | Biotech Hunter